Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 891972, 7 pages
Research Article

Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status

1Laboratorio de Biología Molecular, Unidad de Investigación Médica en Nutrición, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, 4th Floor, Avenida Cuauhtémoc No. 330, Colonia Doctores, Delegación Cuauhtémoc, 06725 México, DF, Mexico
2Servicio de Electrodiagnóstico y Distrofia Muscular, Instituto Nacional de la Rehabilitación, México, DF, Mexico

Received 2 February 2015; Revised 18 March 2015; Accepted 27 March 2015

Academic Editor: Akanchha Kesari

Copyright © 2015 Oriana del Rocío Cruz-Guzmán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Chi B. Vu, Jean E. Bemis, Ericka Benson, Pradeep Bista, David Carney, Richard Fahrner, Diana Lee, Feng Liu, Pallavi Lonkar, Jill C. Milne, Andrew J. Nichols, Dominic Picarella, Adam Shoelson, Jesse Smith, Amal Ting, Allison Wensley, Maisy Yeager, Michael Zimmer, and Michael R. Jirousek, “Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid,” Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Maricela Rodríguez-Cruz, Oriana del Rocío Cruz-Guzmán, Tomás Almeida-Becerril, Alan Donovan Solís-Serna, Salvador Atilano-Miguel, Juan Raúl Sánchez-González, Lourdes Barbosa-Cortés, Eugenia Dolores Ruíz-Cruz, Juan Carlos Huicochea, Alan Cárdenas-Conejo, Rosa Elena Escobar-Cedillo, Carlos Alberto Yam-Ontiveros, and Edgar F. Ricárdez-Marcial, “Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial,” Clinical Nutrition, 2017. View at Publisher · View at Google Scholar
  • Sophie Lecompte, Sonia M. Brichard, Michel Abou-Samra, Raphaël Boursereau, and Laurence Noel, “Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy,” American Journal of Pathology, vol. 187, no. 7, pp. 1577–1585, 2017. View at Publisher · View at Google Scholar
  • Andrea Lizio, Eleonora Maestri, Valeria Ada Sansone, Stanley H. Appel, Adriano Chiò, Christian Lunetta, Gabriele Mora, and Robert G. Miller, “Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis,” JAMA Neurology, vol. 74, no. 6, pp. 660–667, 2017. View at Publisher · View at Google Scholar
  • Lily Pal, Niraj Kumar Srivastava, Ramakant Yadav, Somnath Mukherjee, and Neeraj Sinha, “Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease,” Magnetic Resonance Imaging, vol. 38, pp. 163–173, 2017. View at Publisher · View at Google Scholar
  • J P Gomez, C Gonçalves, C Pichon, and P Midoux, “Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle,” Gene Therapy, 2017. View at Publisher · View at Google Scholar
  • S. Lecompte, M. Abou-Samra, R. Boursereau, L. Noel, and S. M. Brichard, “Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin,” Cellular and Molecular Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Xi Yin, Ying Tang, Bing Wang, Jian Li, Anna T. Dzuricky, Chuanqiang Pu, and Freddie Fu, “Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function,” Muscle and Nerve, vol. 56, no. 4, pp. 759–767, 2017. View at Publisher · View at Google Scholar
  • Antoine Boulanger Piette, Dounia Hamoudi, Laetitia Marcadet, Françoise Morin, Anteneh Argaw, Leanne Ward, and Jérôme Frenette, “Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy,” Current Osteoporosis Reports, 2018. View at Publisher · View at Google Scholar
  • Fabio Arturo Iannotti, Ester Pagano, Aniello Schiano Moriello, Filomena Grazia Alvino, Nicolina Cristina Sorrentino, Luca D'Orsi, Elisabetta Gazzerro, Raffaele Capasso, Elvira De Leonibus, Luciano De Petrocellis, and Vincenzo Di Marzo, “Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice,” British Journal of Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Samara Camaçari de Carvalho, Cintia Yuri Matsumura, Humberto Santo Neto, and Maria Julia Marques, “Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy,” Cytokine, vol. 102, pp. 55–61, 2018. View at Publisher · View at Google Scholar
  • David P. Burns, Leonie Canavan, Jane Rowland, Robin O'Flaherty, Molly Brannock, Sarah E. Drummond, Dervla O'Malley, Deirdre Edge, and Ken D. O'Halloran, “ Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2 ,” The Journal of Physiology, 2018. View at Publisher · View at Google Scholar